India: Guinea Pig to the World_Wired Mag
The pharmaceutical industry’s dilemma: there are few volunteers in the drug-consuming prosperous countries–so they have taken half their business to underdeveloped countries.
Six Healthy Volunteers in Phase I Drug Trial-Critically Ill_UK
The Phase I trial–the first in humans–was set up by US drug research company Parexel International Corp on behalf of German pharmaceutical company TeGenero.
Humbling Reality–Treatments for Depression Often Fail_Boston Globe
The Boston Globe reports (below): “More than 50 years after psychiatrists began widely dispensing drugs to treat mental illness, the profession is coming face to face with a humbling reality: Its treatments often fail, leaving millions of patients [ ] to suffer while doctors search for something that works.”
Another Study Shows: Antipsychotic Trials Biased Towards Sponsor’s Drug
An independent review by a team of German analysts published in the American Journal of Psychiatry confirms that corporate bias is ubiquitous in clinical trials.
Big Pharma: The Fool’s Gold that Heals_New Book
Big Pharma by Jacky Law reveals that in essence, most of the pharmaceutical industry’s claims are false; it is not the drug, but the placebo effect whose potency deserves almost all of the credit for any health improvement:
FDA rules aim to speed drug tests and trim costs
The Food and Drug Administration yesterday issued new guidelines that make it easier for scientists working in universities and small companies to test promising therapies in humans without matching the hefty spending of large drug companies.
Top SFBC officials Quit Amid Senate Inquiry Clinical Trials_ Bloomberg News
In its continuing coverage of corrupt clinical drug trial practices, Bloomberg News reports that all three founders of SFBC International, one of the largest clinical trial business operations that had failed to even screen human subjects for turberculosis, and threatened others with deportation if they refused to become guinea pigs, quit after the Senate Finance committee began investigating drug trial safety issues:
NIMH-funded antidepression drug efficacy / safety studies_What do they prove?
Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants—as tested in the “real world”—were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.
Montreal Clinical Trial Subjects Expoxed to Tuberculosis
Bloomberg News published an update to its sensational special report: Big Pharma’s Shameful Secret
see: https://ahrp.org/infomail/05/11/03.php
Big Pharma’s Shameful Secret
"Every year, drug companies spend $14 billion to test experimental substances on humans. Across the U.S., the centers that do the testing–and the regulators who watch them–allow scores of human test subjects to be injured or killed."